This designation expands the addressable population for NRX-100 to the 13 million Americans who consider suicide each year and represents a 10x expansion of the addressable population compared to the Designation granted in 2017 for bipolar depression alone The Designation includes an FDA determination that NRX-100 has the potential to address an unmet need, based on FDA's assessment of the data submitted Determination of "unmet need" is a requirement for a Commissioner's National Priority Voucher (CNPV) program. Suicide is a public health crisis.

IRVINE, Calif.--(BUSINESS WIRE)---- $MLNK #digitallending--MeridianLink today announced financial results for the second quarter ended June 30, 2025.

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Aerospace IPOs are surging in 2025. ETF plays like UFO and ARKX drawing investor interest.

If you've been paying attention to collector culture over the last decade, you know Funko was once the king of the hill. Its Pop! vinyl figures exploded into the mainstream, plastering the shelves of comic shops, big-box retailers, and even office desks across America.

Make no mistake, friends, this market is still playing favorites. Tech darlings hog the headlines, while other names quietly put up monster numbers in the shadows.

Amazon's Q2 results were solid and in line with my expectations, despite a steep post-earnings sell-off that I view as unjustified. Key growth drivers - cloud, advertising and 3rd party - are performing at or above my case assumptions, supporting long-term upside. My updated DCF analysis shows Amazon is fairly valued even in a pessimistic scenario, with up to 93% upside in the bull case.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the Company will present new data from its hypertension and transthyretin amyloidosis (ATTR) programs at the upcoming European Society of Cardiology (ESC) Congress 2025, taking place in Madrid, Spain, from August 29 - September 1, 2025. These presentations will highlight the potential of RNAi therapeutics to transform the treatment of cardiovascular diseas.

NEW YORK--(BUSINESS WIRE)--Unit, the leading embedded finance provider, today announced that its banking technology powers Wix Checking1, the new integrated business banking solution launched by Wix.com Ltd. (NASDAQ: WIX), the leading SaaS website builder platform globally2. The partnership provides Wix Payments users in the U.S. access to a fully integrated business checking account directly within the Wix platform, including immediate access to their Wix sales. Powered by Unit's technology, W.

LOS ANGELES--(BUSINESS WIRE)--Motorcar Parts of America, Inc. (Nasdaq: MPAA) today reported results for its fiscal 2026 first quarter -- reflecting record sales and gross profit for a fiscal first quarter with solid cash flow generation. Key highlights for the quarter: Net sales increased 10.9 percent to a first quarter record of $188.4 million. Gross profit increased 16.3 percent to a first quarter record of $33.9 million. Operating income increased to $20.1 million from an operating loss of $.

AUSTIN, Texas--(BUSINESS WIRE)---- $EMPD #BTC--Empery Digital Inc. (NASDAQ: EMPD) (the “Company” or “Empery Digital”) today announced that since the last update on August 6, 2025, the Company has acquired an additional 17.51 BTC for a total purchase price of $2.0 million. As of the time of this release, the Company holds 4,018.36 BTC acquired for an aggregate purchase price of approximately $472 million, reflecting an average purchase price of $117,552 per BTC. Additionally, the Company today announced that i.

WAYZATA, Minn.--(BUSINESS WIRE)--MCVT (NASDAQ: MCVT) (the "Company" or "MCVT"). Key Highlights: Treasury: MCVT held 81,871,794 SUI as of August 10, 2025. Since last update 5,600,607 SUI have been purchased at an average price of $3.65 per SUI. Net Asset Value: Using the August 10, 2025 price of $3.85 per SUI, the 81,871,794 SUI are valued at $316 million. SUI per Share: Using 89.08 million shares issued and outstanding on August 10, 2025, MCVT has approximately 0.92 SUI per common share, or $3.

CONSHOHOCKEN, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the Canaccord Genuity 45th Annual Growth Conference on Tuesday, Aug. 12, 2025 at 10:30 A.M. EDT.

NEWTOWN SQUARE, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today reported financial results for the second quarter ended June 30, 2025, and highlighted recent Company progress.

Patients treated with Cylembio (imsapepimut and etimupepimut, adjuvanted) plus pembrolizumab achieved improvement in progression free survival (PFS) compared to patients treated with pembrolizumab monotherapy, HR=0.77 (CI 0.58-1.00), (p=0.056), with median PFS (mPFS) of 19.4 months vs. 11.0 months, respectively; the results on the primary endpoint narrowly missed the study's statistical significance threshold of p≤0.045 In patients enrolled in this study without prior neo-adjuvant/adjuvant anti-PD-1 treatment (n=371), patients treated with Cylembio plus pembrolizumab achieved improvement in PFS, HR: 0.74 (CI 0.56-0.98) (nominal p=0.037), with mPFS of 24.8 months vs.

Presentation of interim analysis from approximately 25 six-month evaluable BCG-Unresponsive patients in the ongoing ADVANCED-2 trial expected at a medical conference in 1Q 2026 Dosing of first patient in THRIVE-3 registrational trial of IV Choline Chloride in patients dependent on parenteral support on track for 3Q 2025 On track to provide an interim update from the Phase 2 STARBORN-1 trial of TARA-002 in pediatric LMs patients in 4Q 2025 Cash, cash equivalents and investments of approximately $146 million as of June 30, 2025, expected to support planned operations into mid-2027 NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, …

CENTER VALLEY, Pa. & KENT, Wash.--(BUSINESS WIRE)--Shift4 Payments, Inc. (“Shift4”) (NYSE: FOUR), the leader in integrated payments and commerce technology, and Blue Origin, the pioneering space exploration company, are working together to enable customers to pay in cryptocurrency and stablecoins for trips to space. Starting today and powered by Shift4's seamless payments technology, consumers can pay with popular cryptocurrencies and stablecoins like Bitcoin, Ethereum, Solana, USDT and USDC fo.

FREMONT, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of the IQ® Battery 5P™ with FlexPhase for customers in Australia. The IQ Battery 5P with FlexPhase is an all-in-one AC-coupled system that delivers reliable backup power and supports both single-phase and three-phase applications with variable power levels, offering flexibility to meet diverse home energy needs.

Beijing, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Mr. Yu He, Chairman of Beijing KUKE Music Co., Ltd.

MINNEAPOLIS, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that its Board of Directors has authorized the repurchase of up to $200 million of the company's outstanding shares of common stock.